glp-1 plus gip & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) The Sustained Effects of a

Figure 1 Figure 2 The discovery of the second incretin, GLP-1, originated from observations in 1982 that anglerfish proglucagon mRNA contained coding sequences of glucagon-related peptide, flanked by pairs of basic amino acids characteristic of the sites cleaved during post-translational processing of prohormones ( Figure 1 Section A]

It then tells you how many units on your syringe equal a specific milligram dose

GLP-1 receptor activated insulin secretion from pancreatic -cells: mechanism and glucose dependence

The point is that they appear to be systemic metabolic therapies with effects that reach beyond simple appetite suppression